4FQM | pdb_00004fqm

Structure of B/Brisbane/60/2008 Influenza Hemagglutinin


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.45 Å
  • R-Value Free: 
    0.268 (Depositor), 0.226 (DCC) 
  • R-Value Work: 
    0.257 (Depositor) 
  • R-Value Observed: 
    0.258 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 4FQM

Ligand Structure Quality Assessment 


This is version 2.2 of the entry. See complete history

Literature

Highly conserved protective epitopes on influenza B viruses.

Dreyfus, C.Laursen, N.S.Kwaks, T.Zuijdgeest, D.Khayat, R.Ekiert, D.C.Lee, J.H.Metlagel, Z.Bujny, M.V.Jongeneelen, M.van der Vlugt, R.Lamrani, M.Korse, H.J.Geelen, E.Sahin, O.Sieuwerts, M.Brakenhoff, J.P.Vogels, R.Li, O.T.Poon, L.L.Peiris, M.Koudstaal, W.Ward, A.B.Wilson, I.A.Goudsmit, J.Friesen, R.H.

(2012) Science 337: 1343-1348

  • DOI: https://doi.org/10.1126/science.1222908
  • Primary Citation Related Structures: 
    4FQH, 4FQI, 4FQJ, 4FQK, 4FQL, 4FQM, 4FQV, 4FQY

  • PubMed Abstract: 

    Identification of broadly neutralizing antibodies against influenza A viruses has raised hopes for the development of monoclonal antibody-based immunotherapy and "universal" vaccines for influenza. However, a substantial part of the annual flu burden is caused by two cocirculating, antigenically distinct lineages of influenza B viruses. Here, we report human monoclonal antibodies, CR8033, CR8071, and CR9114, that protect mice against lethal challenge from both lineages. Antibodies CR8033 and CR8071 recognize distinct conserved epitopes in the head region of the influenza B hemagglutinin (HA), whereas CR9114 binds a conserved epitope in the HA stem and protects against lethal challenge with influenza A and B viruses. These antibodies may inform on development of monoclonal antibody-based treatments and a universal flu vaccine for all influenza A and B viruses.


  • Organizational Affiliation
    • Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

Macromolecule Content 

  • Total Structure Weight: 360.44 kDa 
  • Atom Count: 24,446 
  • Modeled Residue Count: 3,060 
  • Deposited Residue Count: 3,156 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Hemagglutinin HA1
A, C, E, G, I
A, C, E, G, I, K
347Influenza B virus (B/Brisbane/60/2008)Mutation(s): 0 
Gene Names: HA
UniProt
Find proteins for C0LT38 (Influenza B virus)
Explore C0LT38 
Go to UniProtKB:  C0LT38
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupC0LT38
Glycosylation
Glycosylation Sites: 7
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Hemagglutinin HA2
B, D, F, H, J
B, D, F, H, J, L
179Influenza B virus (B/Brisbane/60/2008)Mutation(s): 0 
Gene Names: HA
UniProt
Find proteins for C0LT38 (Influenza B virus)
Explore C0LT38 
Go to UniProtKB:  C0LT38
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupC0LT38
Glycosylation
Glycosylation Sites: 1
Sequence Annotations
Expand
Reference Sequence

Oligosaccharides

Help  
Entity ID: 3
MoleculeChains Length2D Diagram GlycosylationD Interactions
beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
AA [auth a],
DA [auth d],
IA [auth i],
JA [auth j],
KA [auth k],
AA [auth a],
DA [auth d],
IA [auth i],
JA [auth j],
KA [auth k],
M,
NA [auth n],
OA [auth o],
P,
Q,
R,
T,
U,
V,
Y,
Z
3N-Glycosylation
Glycosylation Resources
GlyTouCan: G15407YE
GlyCosmos: G15407YE
GlyGen: G15407YE
Entity ID: 4
MoleculeChains Length2D Diagram GlycosylationD Interactions
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
BA [auth b],
CA [auth c],
EA [auth e],
FA [auth f],
GA [auth g],
BA [auth b],
CA [auth c],
EA [auth e],
FA [auth f],
GA [auth g],
HA [auth h],
LA [auth l],
MA [auth m],
N,
O,
S,
W,
X
2N-Glycosylation
Glycosylation Resources
GlyTouCan: G42666HT
GlyCosmos: G42666HT
GlyGen: G42666HT

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG

Query on NAG



Download:Ideal Coordinates CCD File
AB [auth G]
BB [auth H]
CB [auth I]
DB [auth I]
EB [auth J]
AB [auth G],
BB [auth H],
CB [auth I],
DB [auth I],
EB [auth J],
FB [auth K],
PA [auth A],
QA [auth A],
RA [auth B],
SA [auth C],
TA [auth C],
UA [auth C],
VA [auth D],
WA [auth E],
XA [auth E],
YA [auth F],
ZA [auth G]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.45 Å
  • R-Value Free:  0.268 (Depositor), 0.226 (DCC) 
  • R-Value Work:  0.257 (Depositor) 
  • R-Value Observed: 0.258 (Depositor) 
Space Group: P 21 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 138.69α = 90
b = 242.54β = 90
c = 135.55γ = 90
Software Package:
Software NamePurpose
Blu-Icedata collection
PHASERphasing
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2012-08-22
    Type: Initial release
  • Version 1.1: 2012-10-03
    Changes: Database references
  • Version 1.2: 2017-11-15
    Changes: Refinement description
  • Version 1.3: 2018-01-31
    Changes: Database references
  • Version 2.0: 2020-07-29
    Type: Remediation
    Reason: Carbohydrate remediation
    Changes: Advisory, Atomic model, Data collection, Database references, Derived calculations, Structure summary
  • Version 2.1: 2023-09-13
    Changes: Data collection, Database references, Refinement description, Structure summary
  • Version 2.2: 2024-10-30
    Changes: Structure summary